Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-938P is a pseudogene copy of the gene encoding U6 small nuclear RNA (snRNA), which is a core component of the spliceosome RNA-protein complex responsible for pre-mRNA splicing in eukaryotes[1][3][5]. The U6 snRNA gene is highly conserved and essential for splicing; however, pseudogenes like RNU6-938P are generally considered non-functional remnants of gene duplication, and are not transcribed into active snRNA or involved in RNA splicing[4][5]. The human genome contains many such snRNA pseudogenes, and while some pseudogenes may have a regulatory role through RNA-mediated mechanisms, there is no evidence that RNU6-938P has any such function[5][4]. RNU6-938P is not considered a therapeutic target, and there are no associated drugs, biomarkers, or disease links specific to this pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 938, pseudogene (RNU6-938P).